Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4–5 chronic kidney disease

被引：0
|
作者：
Yoshifuru Tamura
Masahiro Kosuga
Masahiro Yamashita
Satoru Tomioka
Michiko Sasaki
Tomoyuki Hikita
Hideaki Nakajima
Kenichiro Kojima
Shunya Uchida
机构：
[1] Teikyo University School of Medicine,Division of Nephrology, Department of Internal Medicine
来源：
Clinical and Experimental Nephrology | 2008年 / 12卷
关键词：
Angiotensin II receptor blocker; Candesartan cilexetil; Chronic kidney disease; Hypertension; Renoprotective effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：256 / 263
页数：7
相关论文
共 50 条
  • [11] Effects of telmisartan, an angiotensin II receptor blocker, on vascular failure in hypertensive patients with chronic kidney disease
    Watanabe, Hideki
    Nakagawa, Kunio
    Kakihana, Masaaki
    CIRCULATION, 2007, 116 (16) : 459 - 459
  • [12] Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
    Chen, Ping-Min
    Lai, Tai-Shuan
    Chen, Ping-Yu
    Lai, Chun-Fu
    Wu, VinCent
    Chiang, Wen-Chih
    Chen, Yung-Ming
    Wu, Kwan-Dun
    Tsai, Tun-Jun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (04) : 219 - 226
  • [13] The angiotensin II receptor blocker (ARB) candesartan cilexetil decreases portal vascular resistance in liver cirrhosis
    Ito, M
    Hachiya, A
    Nakano, S
    Hanzawa, M
    Katagiri, M
    Kurita, T
    Matsuzaki, H
    Igarashi, Y
    Iida, K
    Miki, K
    GASTROENTEROLOGY, 2003, 124 (04) : A663 - A663
  • [14] Long-term Effects of Telmisartan, an Angiotensin II Receptor Blocker in Hypertensive Patients with Chronic Kidney Disease
    Watanabe, Hideki
    Nakagawa, Kunio
    Kakhana, Masaaki
    CIRCULATION, 2008, 118 (18) : S624 - S625
  • [15] In vivo blockade of angiotensin II receptor binding in rat kidney comparison of candesartan cilexetil with losartan
    Fabiani, ME
    Dinh, DT
    Nassis, L
    Johnston, CI
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 112A - 112A
  • [16] TELMISARTAN, A RENOPROTECTIVE ANGIOTENSIN RECEPTOR BLOCKER MAY PREVENT PROGRESSION OF CHRONIC KIDNEY DISEASE IN NORMOTENSIVE TYPE 2 DIABETES PATIENTS
    Dhar, G. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S29 - S29
  • [17] Reply to comment on "Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease"
    Chen, Ping-Min
    Lai, Tai-Shuan
    Chen, Ping-Yu
    Chiang, Wen-Chih
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (01) : 95 - 96
  • [18] Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease
    Kondo, J
    Sone, T
    Tsuboi, H
    Mukawa, H
    Morishima, I
    Uesugi, M
    Kona, T
    Kosaka, T
    Yoshida, T
    Numaguchi, Y
    Matsui, H
    Murohara, T
    Okumura, K
    AMERICAN HEART JOURNAL, 2003, 146 (06)
  • [19] Effects of high dose angiotensin II receptor blocker - comparison of Valsartan and Candesartan
    Ohishi, Mitsuru
    Ito, Norihisa
    Takagi, Takashi
    Terai, Minako
    Tatara, Yuji
    Shiota, Atsushi
    Hayashi, Norihiro
    Katsuya, Tomohiro
    Rakugi, Hiromi
    Ogihara, Toshio
    JOURNAL OF HYPERTENSION, 2006, 24 : 364 - 364
  • [20] An Experience of the Use of Angiotensin II Receptor Blocker Losartan in Patients With Metabolic Syndrome and Chronic Kidney Disease
    Beloborodova, A. V.
    Morozova, T. E.
    Shilov, E. M.
    KARDIOLOGIYA, 2010, 50 (08) : 32 - 36
12345